Oxford Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,762
| Closed | -$137K | – | 527 |
|
|
2024
Q4 | $137K | Buy |
+23,762
| New | +$137K | 0.06% | 371 |
|
|
2020
Q1 | – | Sell |
-13,203
| Closed | -$816K | – | 553 |
|
|
2019
Q4 | $816K | Sell |
13,203
-6,329
| -32% | -$391K | 0.02% | 980 |
|
|
2019
Q3 | $1.17M | Buy |
19,532
+5,257
| +37% | +$316K | 0.03% | 847 |
|
|
2019
Q2 | $1.21M | Buy |
+14,275
| New | +$1.21M | 0.03% | 882 |
|
|
2018
Q4 | – | Sell |
-3,762
| Closed | -$333K | – | 1863 |
|
|
2018
Q3 | $333K | Sell |
3,762
-35,264
| -90% | -$3.12M | 0.01% | 1468 |
|
|
2018
Q2 | $4.51M | Buy |
39,026
+6,655
| +21% | +$768K | 0.09% | 246 |
|
|
2018
Q1 | $2.62M | Buy |
32,371
+6,489
| +25% | +$525K | 0.06% | 434 |
|
|
2017
Q4 | $1.53M | Buy |
+25,882
| New | +$1.53M | 0.03% | 716 |
|
|
2017
Q1 | – | Sell |
-142,669
| Closed | -$4.78M | – | 1409 |
|
|
2016
Q4 | $4.78M | Buy |
142,669
+4,917
| +4% | +$165K | 0.17% | 114 |
|
|
2016
Q3 | $3.67M | Buy |
137,752
+63,980
| +87% | +$1.7M | 0.11% | 221 |
|
|
2016
Q2 | $1.63M | Sell |
73,772
-48,685
| -40% | -$1.07M | 0.05% | 403 |
|
|
2016
Q1 | $3.6M | Buy |
122,457
+62,165
| +103% | +$1.83M | 0.1% | 251 |
|
|
2015
Q4 | $2.02M | Buy |
+60,292
| New | +$2.02M | 0.05% | 394 |
|